‘The virus has evolved’: Fifth COVID dose available soon Adults will become eligible for a fifth dose from 20 February, supported by a new incentive for GPs attending aged care and disability facilities.
Smoke and vapours: RACGP warns of Big Tobacco research drive A recent investigation revealed the world’s largest tobacco company has poured hundreds of millions of dollars into vaping research.
How effective are antidepressants for pain? New research has advocated for a ‘more nuanced approach’ when prescribing antidepressants for chronic pain.
Paracetamol pack sizes likely to be reduced: TGA A decision to change the Poisons Standard and cut maximum pack sizes in supermarkets and pharmacies is now going out to consultation.
Antibiotic resistance: Antidepressants an ‘overlooked phenomenon’ New Australian research has found a range of commonly prescribed medications for mental health can make bacteria resistant to antibiotics.
New Parkinson’s drug listed on PBS The adjunctive therapy for the treatment of Parkinson’s disease will help to maximise the effectiveness and longevity of existing medication.
Heart attack risk: Is expanded cholesterol testing warranted? Some specialists say screening is needed to detect ‘bad cholesterol’ linked to heart attacks in younger people, but the RACGP is cautious.
Research shows boosters are ‘crucial’ for protecting vulnerable A new study has examined the impact of COVID-19 boosters for those with more than one chronic condition.
IVF does not affect child development: Study Research shows equal development and educational outcomes for IVF and spontaneously conceived children.
‘Super-spreader’ areas identified in health settings: Study Researchers say low-cost CO2 monitors have an important role to play in identifying the interventions needed to mitigate spread of airborne viruses.